PubMed

Exenatide sensitizes insulin-mediated whole-body glucose disposal and promotes uptake of exogenous glucose by the liver.

Zheng D, Ionut V, Mooradian V, Stefanovski D, Bergman RN.

Diabetes. 2009 Feb;58(2):352-9. Epub 2008 Nov 14.PMID: 19011168 [PubMed - indexed for MEDLINE]Related articlesFree article

Exenatide can reduce glucose independent of islet hormones or gastric emptying.

Ionut V, Zheng D, Stefanovski D, Bergman RN.

Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E269-77. Epub 2008 May 20.PMID: 18492781 [PubMed - indexed for MEDLINE]Related articlesFree article

Inclusion of low amounts of fructose with an intraduodenal glucose load markedly reduces postprandial hyperglycemia and hyperinsulinemia in the conscious dog.

Shiota M, Moore MC, Galassetti P, Monohan M, Neal DW, Shulman GI, Cherrington AD.

Diabetes. 2002 Feb;51(2):469-78.PMID: 11812757 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of pioglitazone on hepatic glucose uptake measured with indirect and direct methods in alloxan-induced diabetic dogs.

Matsuhisa M, Shi ZQ, Wan C, Lekas M, Rodgers CD, Giacca A, Kawamori R, Vranic M.

Diabetes. 1997 Feb;46(2):224-31.PMID: 9000698 [PubMed - indexed for MEDLINE]Related articles

The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans.

Roden M, Perseghin G, Petersen KF, Hwang JH, Cline GW, Gerow K, Rothman DL, Shulman GI.

J Clin Invest. 1996 Feb 1;97(3):642-8.PMID: 8609218 [PubMed - indexed for MEDLINE]Related articlesFree article

Interaction of a selective serotonin reuptake inhibitor with insulin in the control of hepatic glucose uptake in conscious dogs.

Moore MC, DiCostanzo CA, Dardevet D, Lautz M, Farmer B, Cherrington AD.

Am J Physiol Endocrinol Metab. 2005 Mar;288(3):E556-63. Epub 2004 Nov 2.PMID: 15522992 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes.

Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk FW, Holst JJ, Rizza RA.

Diabetes. 2001 Mar;50(3):565-72.PMID: 11246876 [PubMed - indexed for MEDLINE]Related articlesFree article

Exenatide: an incretin mimetic for the treatment of type 2 diabetes mellitus.

Iltz JL, Baker DE, Setter SM, Keith Campbell R.

Clin Ther. 2006 May;28(5):652-65. Review.PMID: 16861088 [PubMed - indexed for MEDLINE]Related articles

Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.

Cusi K, Consoli A, DeFronzo RA.

J Clin Endocrinol Metab. 1996 Nov;81(11):4059-67.PMID: 8923861 [PubMed - indexed for MEDLINE]Related articles

Small amounts of fructose markedly augment net hepatic glucose uptake in the conscious dog.

Shiota M, Galassetti P, Monohan M, Neal DW, Cherrington AD.

Diabetes. 1998 Jun;47(6):867-73.PMID: 9604861 [PubMed - indexed for MEDLINE]Related articlesFree article

Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes.

Cervera A, Wajcberg E, Sriwijitkamol A, Fernandez M, Zuo P, Triplitt C, Musi N, DeFronzo RA, Cersosimo E.

Am J Physiol Endocrinol Metab. 2008 May;294(5):E846-52. Epub 2008 Mar 11.PMID: 18334612 [PubMed - indexed for MEDLINE]Related articlesFree article

Intraportally delivered GLP-1, in the presence of hyperglycemia induced via peripheral glucose infusion, does not change whole body glucose utilization.

Johnson KM, Edgerton DS, Rodewald T, Scott M, Farmer B, Neal D, Cherrington AD.

Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E380-4. Epub 2007 Dec 4.PMID: 18056788 [PubMed - indexed for MEDLINE]Related articlesFree article

Glucosamine-induced inhibition of liver glucokinase impairs the ability of hyperglycemia to suppress endogenous glucose production.

Barzilai N, Hawkins M, Angelov I, Hu M, Rossetti L.

Diabetes. 1996 Oct;45(10):1329-35.PMID: 8826967 [PubMed - indexed for MEDLINE]Related articles

Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes.

Linnebjerg H, Park S, Kothare PA, Trautmann ME, Mace K, Fineman M, Wilding I, Nauck M, Horowitz M.

Regul Pept. 2008 Nov 29;151(1-3):123-9. Epub 2008 Jul 16.PMID: 18675854 [PubMed - indexed for MEDLINE]Related articles

Interaction of insulin and prior exercise in control of hepatic metabolism of a glucose load.

Pencek RR, James F, Lacy DB, Jabbour K, Williams PE, Fueger PT, Wasserman DH.

Diabetes. 2003 Aug;52(8):1897-903.PMID: 12882903 [PubMed - indexed for MEDLINE]Related articlesFree article

Glucagon-like peptide-1 (7-37) augments insulin-mediated glucose uptake in elderly patients with diabetes.

Meneilly GS, McIntosh CH, Pederson RA, Habener JF, Gingerich R, Egan JM, Elahi D.

J Gerontol A Biol Sci Med Sci. 2001 Nov;56(11):M681-5.PMID: 11682575 [PubMed - indexed for MEDLINE]Related articles

Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange.

DeFronzo RA, Ferrannini E, Hendler R, Wahren J, Felig P.

Proc Natl Acad Sci U S A. 1978 Oct;75(10):5173-7.PMID: 283423 [PubMed - indexed for MEDLINE]Related articlesFree article

Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.

Henriksen JE, Levin K, Thye-Rønn P, Alford F, Hother-Nielsen O, Holst JJ, Beck-Nielsen H.

Diabetes. 2000 Jul;49(7):1209-18.PMID: 10909980 [PubMed - indexed for MEDLINE]Related articlesFree article

A negative arterial-portal venous glucose gradient decreases skeletal muscle glucose uptake.

Galassetti P, Shiota M, Zinker BA, Wasserman DH, Cherrington AD.

Am J Physiol. 1998 Jul;275(1 Pt 1):E101-11.PMID: 9688880 [PubMed - indexed for MEDLINE]Related articlesFree article

Metabolic effects of the incretin mimetic exenatide in the treatment of type 2 diabetes.

Schnabel CA, Wintle M, Kolterman O.

Vasc Health Risk Manag. 2006;2(1):69-77. Review.PMID: 17319471 [PubMed - indexed for MEDLINE]Related articlesFree article